Benign gynecological diseases and women’s health burden: time to remove the invisibility cloak

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (18)

• Deciding on the appropriate pharmacotherapy for the treatment of endometriosis via openalex
• Global, regional, and national burden of endometriosis among women of childbearing age from 1990 to 2021: a cross-sectional analysis from the 2021 global burden of disease study via openalex
• Global, regional, and national prevalence and trends of gynecological diseases among women of childbearing age from 1990 to 2021: An analysis of the global burden of disease study 2021 via openalex
• Horizons in Endometriosis: Proceedings of the Montreux Reproductive Summit, 14-15 July 2023 via openalex
• Investigating the medical journey of endometriosis-affected women: Results from a cross-sectional web-based survey (EndoVie) on 1,557 French women via openalex
• “Ladies first”: a plea for prioritizing women’s inclusion in the research and health care agenda via openalex
• The importance of quantifying the adverse effects on healthcare-related quality of life in people with benign gynecologic conditions via openalex
• W4404566671 via openalex
• W4409630922 via openalex
• W4411360421 via openalex
• W4412156676 via openalex
• W4400105765 via openalex
• W4377139502 via openalex
• W4385799520 via openalex
• W4388870170 via openalex
• W3126049569 via openalex
• W4403760586 via openalex
• W4404096631 via openalex

Source provenance

openalex

last seen: 2026-06-10T17:14:06.276822+00:00